Please Wait
Applying Filters...
menu
    • menu
    Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    Azilsartan

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,316Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name MF Registration No. Classification Initial Date of Reg. Latest Date of Reg. Registrant's Address
    29/11/2025 Eisai
    Japan
    		 EISAI PHARMACEUTICALS INDIA PVT LTD 305MF10020 Azilsartan 2023-02-08 2023-02-08 Ⅴisakha PharmaCity Limited (SEZ), Plot Nos. 96,97,98,124&126, Parawada-531 019, Anakapalli District, A. P. , India
    29/11/2025 Jiangxi Synergy Pharmaceutical
    China
    		 Jiangxi Synergy Pharmaceutical Co. , Ltd. 305MF10141 Azilsartan 2023-12-22 2023-12-22 Jiangxi Fengxin Industrial Park, Fengxin, County, 330700, Yichun City, Jiangxi Province, China.